Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.)
|
Balance Sheets |
|||||||
|
Metropolitan |
Republic |
||||||
|
Assets |
|||||||
|
Cash |
$ |
282.3 |
$ |
43.1 |
|||
|
Accounts receivable (net) |
513.7 |
416.0 |
|||||
|
Short-term investments |
— |
8.3 |
|||||
|
Inventories |
562.4 |
719.2 |
|||||
|
Prepaid expenses and other current assets |
216.6 |
576.7 |
|||||
|
Current assets |
$ |
1,575.0 |
$ |
1,763.3 |
|||
|
Property, plant, and equipment (net) |
2,702.2 |
2,656.5 |
|||||
|
Intangibles and other assets |
297.3 |
597.9 |
|||||
|
Total assets |
$ |
4,574.5 |
$ |
5,017.7 |
|||
|
Liabilities and Shareholders’ Equity |
|||||||
|
Accounts payable |
$ |
572.9 |
$ |
781.2 |
|||
|
Short-term notes |
312.1 |
644.4 |
|||||
|
Accruals and other current liabilities |
685.2 |
620.5 |
|||||
|
Current liabilities |
$ |
1,570.2 |
$ |
2,046.1 |
|||
|
Long-term debt |
648.6 |
648.3 |
|||||
|
Deferred tax liability |
474.6 |
703.7 |
|||||
|
Other long-term liabilities |
215.0 |
193.1 |
|||||
|
Total liabilities |
$ |
2,908.4 |
$ |
3,591.2 |
|||
|
Common stock (par and additional paid-in capital) |
229.9 |
440.0 |
|||||
|
Retained earnings |
2,567.9 |
1,695.9 |
|||||
|
Less: Treasury stock |
(1,131.7 |
) |
(709.4 |
) |
|||
|
Total liabilities and shareholders’ equity |
$ |
4,574.5 |
$ |
5,017.7 |
|||
|
Income Statements |
|||||||
|
Net sales |
$ |
5,794.0 |
$ |
7,856.2 |
|||
|
Cost of goods sold |
(2,818.0 |
) |
(4,385.7 |
) |
|||
|
Gross profit |
$ |
2,976.0 |
$ |
3,470.5 |
|||
|
Operating expenses |
(1,649.7 |
) |
(2,933.2 |
) |
|||
|
Interest expense |
(83.8 |
) |
(43.6 |
) |
|||
|
Income before taxes |
$ |
1,242.5 |
$ |
493.7 |
|||
|
Tax expense |
(295.7 |
) |
(68.1 |
) |
|||
|
Net income |
$ |
946.8 |
$ |
425.6 |
|||
|
Net income per share |
$ |
1.6 |
$ |
7.7 |
|||
Evaluate and compare the two companies by responding to the
following questions.
Note: Because comparative statements are not
provided you should use year-end balances in place of average
balances as appropriate.
|
Metropolitan |
Republic |
|||
|
Return on Assets |
% |
% |
||
|
Profit Margin |
% |
% |
||
|
Asset Turnover |
times |
times |
||
|
Return on Shareholders' Equity |
% |
% |
||
|
Equity Multiplier |
||||
|
Acid-Test Ratio |
||||
|
Current Ratio |
||||
|
Receivables Turnover |
times |
times |
||
|
Inventory Turnover |
times |
times |
||
|
Times Interest Earned |
times |
times |
||
Of the two companies, which appears riskier in terms of its ability to pay short-term obligations?
Which of the two companies manages their current assets more efficiently?
From the perspective of a creditor, which company offers the most comfortable margin of safety in terms of its ability to pay fixed interest charges?



Presented below are condensed financial statements adapted from those of two actual companies competing as the...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic Assets Cash $ 282.3 $ 43.1 Accounts receivable (net) 513.7 416.0 Short-term investments — 8.3 Inventories 562.4 719.2 Prepaid expenses and other current assets 216.6 576.7 Current assets $ 1,575.0 $ 1,763.3 Property, plant, and equipment (net) 2,702.2 2,656.5 Intangibles...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic Assets Cash $ 282.3 $ 43.1 Accounts receivable (net) 513.7 416.0 Short-term investments — 8.3 Inventories 562.4 719.2 Prepaid expenses and other current assets 216.6 576.7 Current assets $ 1,575.0 $ 1,763.3 Property, plant, and equipment (net) 2,702.2 2,656.5 Intangibles...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution Industry ($ in millions, except per share amounts.) Balance Sheets Metropolitan $ 232.3 465.7 519.4 172.6 $ 1,381.6 2,656.2 256.3 $ 4,293.5 Republic $ 42.0 365. 7.4 673.2 533.7 $ 1,621.3 2,348.3 528.6 $ 4,498.1 Assets Cash Accounts receivable (net) Short-term investments Inventory Prepaid expenses and other current assets Current assets Property,...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution Industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic $ 232.3 465.7 510.4 172.6 $ 1,381.6 2,656.2 256.3 $ 4,293.5 $ 42.8 365.6 7.4 673.2 533.7 $ 1,621.3 2,348.3 528.6 $ 4,498.1 Assets Cash Accounts receivable (net) Short-term investments Inventory Prepaid expenses and other current assets Current assets Property,...
Presented below are condensed financial statements adapted from those of two actual companies competing as the primary players in a specialty area of the food manufacturing and distribution industry. ($ in millions, except per share amounts.) Balance Sheets Metropolitan Republic Assets Cash $ 289.3 $ 43.3 Accounts receivable (net) 522.7 423.0 Short-term investments — 8.5 Inventory 572.4 725.2 Prepaid expenses and other current assets 225.6 587.7 Current assets $ 1,610.0 $ 1,787.7 Property, plant, and equipment (net) 2,707.2 2,712.9 Intangibles...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 16,779 $ 11,244 Short-term investments 6,144 12,400 Accounts receivable (net) 8,894 11,095 Inventories 5,744 9,603 Other current assets 5,790 5,655 Current assets 43,351 49,997 Property, plant, and equipment (net) 15,542 23,983 Intangibles and other assets...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 10,641 $ 5,801 Short-term investments 5,037 11,293 Accounts receivable (net) 7,589 9,790 Inventories 4,520 7,459 Other current assets 4,395 4,260 Current assets 32,182 38,603 Property, plant, and equipment (net) 12,338 20,779 Intangibles and other assets...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry, Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 9,959 $ 5,184 Short-term investments 4,914 11,170 Accounts receivable (net) 7,444 9,645 Inventories 4,384 7,233 Other current assets 4,240 4,105 Current assets 30,941 37,337 Property, plant, and equipment (net) 11,982 20.423 Intangibles and other...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 14,733 $ 9,453 Short-term investments 5,775 12,031 Accounts receivable (net) 8,459 10,660 Inventories 5,336 8,865 Other current assets 5,325 5,190 Current assets 39,628 46,199 Property, plant, and equipment (net) 14,474 22,915 Intangibles and other assets...
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industry—Johnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) J&J Pfizer Assets: Cash $ 18,143 $ 12,398 Short-term investments 6,390 12,646 Accounts receivable (net) 9,184 11,385 Inventories 6,016 10,135 Other current assets 6,100 5,965 Current assets 45,833 52,529 Property, plant, and equipment (net) 16,254 24,695 Intangibles and other assets...